Table 16:
Disutilities Used in the Economic Model
| Health State | Disutility | Standard Deviation | Duration | Source |
|---|---|---|---|---|
| Treatment-Related Disutilities | ||||
| LAAC device implantation | 0.060 | 0.0012 | One-time | Garg et al, 200867 |
| Aspirin | 0.002 | 0.0004 | Ongoing | Gage et al, 199665 |
| Apixaban | 0.006 | 0.0012 | Ongoing | O'Brien et al, 200566 |
| Dabigatran | 0.006 | 0.0012 | Ongoing | O'Brien et al, 200566 |
| Rivaroxaban | 0.006 | 0.0012 | Ongoing | O'Brien et al, 200566 |
| Warfarin | 0.013 | 0.0026 | Ongoing | Gage et al, 199665 |
| Event-Related Disutilities | ||||
| Device embolization | 0.250 | 0.0558 | One-time | Saw et al, 201636 |
| Pericardial effusion | 0.159 | 0.0318 | One-time | Saw et al, 201636 |
| Major bleed | 0.159 | 0.172 | One-time | Thomson et al, 200068 |
| Minor bleed | 0.011 | 0.011 | One-time | Thomson et al, 200068 |
| Systemic embolism | 0.279 | 0.0558 | One-time | Sullivan et al, 200569 |
Abbreviation: LAAC device, left atrial appendage closure device with delivery system.